Group B Streptococcus Vaccine Shows Promise in Phase 2 Study
Study shows maternal vaccination with Pfizer’s hexavalent capsular polysaccharide conjugate vaccine may protect infants against Group B Streptococcus.
Stay updated with breaking news from Groupb Streptococcus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Study shows maternal vaccination with Pfizer’s hexavalent capsular polysaccharide conjugate vaccine may protect infants against Group B Streptococcus.
Research teams are investigating new treatments to improve the health of women across the borough.
Pfizer Inc. announced data from a Phase 2 study investigating its hexavalent capsular polysaccharide conjugate Group B Streptococcus vaccine candidate, GBS6, being developed for maternal...
Benzinga Tesla Recalls More Than 17,000 EVs Over Camera, Seat Belt Issues Tesla Inc (NASDAQ: TSLA) has issued a recall for over 1,300 Model S, X, and Y vehicles made in 2023, citing an issue with the forward-facing front camera, and over 15,000 Model S and X vehicles for problems related to front-row seat belts. According to safety recall reports uploaded on the National Highway Traffic Safety Administration website, the front-facing camera might be misaligned on certain 2023 Model S, X, and Y v
Results from an ongoing Phase 2 study in pregnant individuals showed the investigational vaccine, GBS6, was generally well-tolerated and generated robust maternal antibody responses that were efficiently transferred to infants The safety profile between the vaccine and placebo groups was similar in both the mothers and infants GBS6 maternal vaccination may offer meaningful protection against invasive GBS disease in newborns and young infants, based on a natural history study conducted in parallel to the Phase 2 study